Phenotyping of Stable Left Ventricular Assist Device Patients Using Noninvasive Pump Flow Responses to Acute Loading Transients
Section snippets
Methods
After obtaining informed consent, stable outpatients supported with the HeartWare HVAD (Medtronic LLC, Minneapolis, MN) were studied. Pump flow waveforms were recorded continuously at 50Hz using proprietary software (Medical University of Vienna, Vienna, Austria). Patients sequentially transitioned from the seated position to supine, passive leg raise and standing. Sustained, maximal 2-handed handgrip was performed in the supine position. Transitions between stages were defined as the first 5
Results
Fifteen patients were studied, with baseline characteristics outlined in Table 1. Steady-state measurements are displayed in Fig. 1 and transition measurements in Fig. 2, with all postural data presented in Supplementary Table S1. Transitioning from seated to supine posture produced a transient, significant increase in flow (4.3 ± 0.9 L/min vs 5.1 ± 1.0 L/min, P < .0001), consistent with increased preload, and persisting to a diminished degree at steady state (4.8 ± 0.9 L/min, P = .0002 vs
Discussion
It has been demonstrated in silico that pump flow varies in a predictable fashion according to isolated changes in loading conditions and ventricular contractility, and this variation can potentially provide insights into patient hemodynamics.6,9 However, use of the flow waveform in vivo is complicated by a constant interplay between loading conditions, ventricular performance, pump function, and compensatory mechanisms.10 This study is the first to assess these interactions systematically,
Conclusions
Dynamic maneuvers can have dramatic effects on the pump flow waveform via changes in loading conditions and secondary compensatory responses. Assessment of these effects may allow more individualized, patient-centered care. Automated pump speed algorithms must account for the wide variability in responses across different patients.
Disclosures
Professor Hayward: Medtronic - Speakers' Bureau, Consultancy to individual, Research grant to Hospital, Patent Holder (owned by hospital, Licenced by Medtronic). There are no other relevant disclosures.
References (21)
- et al.
Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support)
J Am Coll Cardiol
(2014) - et al.
HVAD: the ENDURANCE Supplemental Trial
JACC Heart Fail
(2018) - et al.
Dynamic flow responses to expiratory maneuvers in left ventricular assist device patients
J Heart Lung Transplant
(2019) - et al.
3D morphological changes in LV and RV during LVAD ramp studies
JACC Cardiovasc Imaging
(2018) - et al.
A fully magnetically levitated left ventricular assist device - final report
N Engl J Med
(2019) - et al.
Intrapericardial left ventricular assist device for advanced heart failure
N Engl J Med
(2017) - et al.
Patient-reported health-related quality of life is a predictor of outcomes in ambulatory heart failure patients treated with left ventricular assist device compared with medical management: results from the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management)
Circ Heart Fail
(2017) - Muthiah K, Gupta S, Otton J, Robson D, Walker R, Tay A, et al. Body position and activity, but not heart rate, affect...
- et al.
Response of rotary blood pumps to changes in preload and afterload at a fixed speed setting are unphysiological when compared with the natural heart
Artif Organs
(2011) - et al.
Beat-to-beat detection of aortic valve opening in HeartWare left ventricular assist device patients
Artif Organs
(2019)
Cited by (4)
HeartMate 3 Snoopy: Noninvasive cardiovascular diagnosis of patients with fully magnetically levitated blood pumps during echocardiographic speed ramp tests and Valsalva maneuvers
2024, Journal of Heart and Lung TransplantationGlobal best practices consensus: Long-term management of patients with hybrid centrifugal flow left ventricular assist device support
2022, Journal of Thoracic and Cardiovascular SurgeryCitation Excerpt :As shown in Figure 1, different portions of the flow waveform can be examined to assess each of these aspects of cardiac and vascular function.33 The importance of changes in physiological conditions contributing dynamic changes in the pump flow waveform can be in response to position,31 and physiological intervention such as straining, or Valsalva maneuver.34,35 Three immediately useful waveform characteristics to recognize are flow pulsatility (peak flow minus trough flow), evidence of ventricular suction, and changes associated with systemic hypertension because each of these can rapidly direct therapy (Figure 2).
A Sensorless Modular Multiobjective Control Algorithm for Left Ventricular Assist Devices: A Clinical Pilot Study
2022, Frontiers in Cardiovascular Medicine